COVID-19 Miniseries: Multi-System Inflammatory Syndrome (MIS-C) in Pediatric Patients

  • 14m 56s
  • Amit K. Ghosh, M.D., M.B.A., Nipunie S. Rajapakse, M.D., M.P.H.
  • Mayo Clinic Health Solutions
  • 2020

Patients under 21 who present with fever, lab evidence of inflammation, multisystem involvement, and recent or current SARS-CoV-2 infection fall under the case definition for multisystem inflammatory syndrome. They commonly present with persistent fever and gastrointestinal symptoms and concerningly, shock. Why are we seeing disproportionate rates in children of racial and ethnic minorities? Dr. Nipunie Rajapaske concisely covers what’s known about this syndrome and the data supporting its emergence as a post-infection complication.

In this Audiobook

  • Mayo Clinic Talk with Doctor Nipunie Rajapakse on Multi-System Inflammatory Syndrome (MIS-C) in Pediatric Patients